Documentos relacionados

1. Rheumatology in Ukraine.
2. Clinical outcomes of Covid-19 in patients with rheumatic diseases and the effects of the pandemic on rheumatology outpatient care: A single-centre experience from Turkey.
3. Rheumatology training and research in Iran.
4. Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries.
5. Risk factors for herpes zoster in patients with rheumatic diseases: a nationwide cohort study in Korea.
6. The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta <i>et al</i> and 'Antirheumatic agents in covid-19: is IL-6 the right target?' by Capeechi <i>et al</i>.
7. Deriving common comorbidity indices from the MedDRA classification and exploring their performance on key outcomes in patients with rheumatoid arthritis.
8. The National Data Bank for Rheumatic Diseases (NDB).
9. SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey.
10. Fibromyalgia interferes with disease activity and biological therapy response in inflammatory rheumatic diseases.